Showing 5601-5610 of 5909 results for "".
- Galimedix Therapeutics Presents Data for Investigational Eyedrops Containing GAL-101https://modernod.com/news/galimedix-therapeutics-presents-data-for-investigational-eyedrops-containing-gal-101/2476320/Galimedix Therapeutics, which is developing new solutions for ophthalmic and neurodegenerative diseases, presented an overview of data disclosed to date on its novel, first-in-class, investigational compound GAL-101, which in animal models caused sustained prevention of misfolded amyloid beta mol
- Harrow Health Announces $11 Million Series A Financing for Melt Pharmaceuticals Subsidiaryhttps://modernod.com/news/harrow-health-announces-11-million-series-a-financing-for-melt-pharmaceuticals-subsidiary/2476323/Melt Pharmaceuticals, an affiliated company of Harrow Health, announced it has entered into definitive stock purchase agreements with accredited and institutional investors to raise proceeds of approximately $11 million in a private placement sale of its Series A preferred stock at $5 per share.
- CorneaGen to Acquire KeraLink Domestic Eye Bank Operationshttps://modernod.com/news/corneagen-to-acquire-keralink-domestic-eye-bank-operations/2476326/CorneaGen and KeraLink International, a provider of corneal transplantation services, supplies and grafts for transplant, have signed a final agreement for CorneaGen to acquire KeraLink’s domestic eye bank operations and related assets. Financial terms of the deal were not disclosed. <
- SECO International Names J. Max Ernst, OD, as 2020 Presidenthttps://modernod.com/news/seco-international-names-j-max-ernst-od-as-2020-president/2476329/SECO International, the world’s largest educational conference, has announced that J. Max Ernst, OD, will become the next SECO International President. Dr. Ernst will officially accept the honor during the House of Delegates meeting, held during SECO 2019, Saturday, February 23, from 3:15 pm-5 pm
- New US Experiments Aim To Create Gene-Edited Human Embryoshttps://modernod.com/news/new-us-experiments-aim-to-create-gene-edited-human-embryos/2476330/A scientist in New York is conducting experiments designed to modify DNA in human embryos as a step toward someday preventing inherited diseases, according to an NPR
- Spectralis High Magnification Module Receives CE Markinghttps://modernod.com/news/spectralis-high-magnification-module-receives-ce-marking/2476331/Heidelberg Engineering announced CE Mark approval of the Spectralis High Magnification Module. With the addition of a lens and software upgrade, the new module enables visualization of the ocular
- Johnson & Johnson Vision Announces Availability in Europe of Tecnis Eyhance IOLhttps://modernod.com/news/johnson-johnson-vision-announces-availability-in-europe-of-tecnis-eyhance-iol/2476332/Johnson & Johnson Vision announced the launch of its Tecnis Eyhance IOL in Europe. This next-generation monofocal IOL allows patients to experience high-quality vision at both intermediate and far distances. “With the availability of Tecnis Eyhance IOL in Europe, we are proud to deliv
- Clinical Trials Planned for Iris-Recognition-Based Patient Identification Softwarehttps://modernod.com/news/clinical-trials-planned-for-iris-recognition-based-patient-identification-software/2476333/Patientory and UK-based IrisGuard announced a collaboration to combine leading iris biometric technology and healthcare focused PTOYNet blockchain network for enhanced security measures. The HIPAA-compliant Patientory App, which already adheres to strict security requirements, will utilize the be
- Zeimer Manufactured its 1,000th Laser at its Berne Production Facilityhttps://modernod.com/news/zeimer-manufactured-its-1000th-laser-at-its-berne-production-facility/2476335/More than 20 years ago, Ziemer Ophthalmic Systems AG, based in the Berne Seeland region of Switzerland began providing eye surgeons with high-quality products. The company started with a diamond knife and soon develop
- MacuLogix Hosts Inaugural AMD Speaker Alliancehttps://modernod.com/news/maculogix-hosts-inaugural-amd-speaker-alliance/2476336/MacuLogix hosted the industry’s first AMD Speaker Alliance meeting. The peer-to-peer event was attended by 25 optometric key opinion leaders who are at the front lines of minimizing vision loss due to AMD and other retinal disease. “This meeting is helping us kick off a movement in our pro